The association between the SH2-containing inositol polyphosphate 5-phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners

Journal of Cellular Physiology

Volumn 214, Issue 1, 2008, Pages 260-272

  Onnockx, Sheela ^a   De Schutter, Julie ^a   Blockmans, Marianne ^a   Xie, Jingwei ^a   Jacobs, Christine ^b   Vanderwinden, Jean Marie ^b   Erneux, Christophe ^a   Pirson, Isabelle ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; INSULIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN SH2; SH2 CONTAINING INOSITOL POLYPHOSPHATE 5 PHOSPHATASE 2; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

3T3-L1 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADIPOCYTES; AMINO ACID SUBSTITUTION; ANIMALS; CATALYTIC DOMAIN; CELL LINE; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT DYES; GLUTATHIONE TRANSFERASE; HISTIDINE; HUMANS; INSULIN; MICE; MYOBLASTS, SKELETAL; PHOSPHORIC MONOESTER HYDROLASES; PRECIPITIN TESTS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, INSULIN; RECOMBINANT FUSION PROTEINS; SERINE; SUBCELLULAR FRACTIONS; TRANSFECTION; TRYPTOPHAN;

CRICETULUS GRISEUS;

EID: 36849083715     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21193     Document Type: Article

References (48)

1. Ahmed Z, Pillay TS. 2001. Functional effects of APS and SH2-B on insulin receptor signalling. Biochem Soc Trans 29:529-534.
2. Ahmed Z, Smith BJ, Kotani K, Wilden P, Pillay TS. 1999. APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase. Biochem J 341:665-668.
3. Ahmed Z, Smith BJ, Pillay TS. 2000. The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination of the insulin receptor. FEBS Lett 475:31-34.
4. Ahn MY, Katsanakis KD, Bheda F, Pillay TS. 2004. Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling. J Biol Chem 279:21526-21532.
5. Artemenko Y, Gagnon A, Ibrahim S, Sorisky A. 2007. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes.J Cell Physiol 211:598-607.
6. Auethavekiat V, Abrams CS, Majerus PW. 1997. Phosphorylation of platelet pleckstrin activates inositol polyphosphate 5-phosphatase I. J Biol Chem 272:1786-1790.
7. Baykov AA, Evtushenko OA, Avaeva SM. 1988. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme-immunoassay. Anal Biochem 171:266-270.
8. Blero D, De Smedt F, Pesesse X, Paternotte N, Moreau C, Payrastre B, Erneux C. 2001. The 5H2 domain containing inositol S-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin (vol 282, pg 839, 2001). Biochem Biophys Res Commun 284:1090.
9. Cantley LC, Neel BG. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway. Proc Natl Acad Sci USA 96:4240-4245.
10. Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, Neudauer CL, Macara IG, Pessin JE, Saltiel AR. 2001. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410:944-948.
11. Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Marchand-Brustel Y, Erneux C, Hue L, Schurmans S. 2001. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409:92-97.
12. Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Marchand-Brustel Y, Erneux C, Hue L, Schurmans S. 2004. The lipid phosphatase SHIP2 controls insulin sensitivity (vol 409, pg 92, 2001). Nature 431:878.
13. Dhe-Sirano D, Werner ED, Masahiro N, Hansen L, Chi YI, Shoelson SE. 2004. A phenylalanine zipper mediates APS dimerization. Nat Struct Mol Biol 11:968-974.
14. Duan CJ, Yang HY, White MF, Rui LY. 2004. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Mol Cell Biol 24:7435-7443.
15. Dyson JM, O'Malley CJ, Becanovic J, Munday AD, Berndt MC, Coghill ID, Nandurkar HH, Ooms LM, Mitchell CA. 2001. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J Cell Biol 155:1065-1079.
16. Fukui K, Wada T, Kagawa S, Nagira K, Ikubo M, Ishihara H, Kobayashi M, Sasaoka T. 2005. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice. Diabetes 54:1958-1967.
17. Gagnon A, Artemenko Y, Crapper T, Sorisky A. 2003. Regulation of endogenous SH2 domain-containing inositol 5-phosphatase (SHIP2) in 3T3-L1 and human preadipocytes. J Cell Physiol 197:243-250.
18. Gunton JE, Kulkami RN, Yim SH, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, Kahn CR. 2005. Loss of ARNT/HIF1 beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122:337-349.
19. Habib T, Hejna JA, Moses RE, Decker SJ. 1998. Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein. J Biol Chem 273:18605-18609.
20. Harada K, Takeuchi H, Oike M, Matsuda M, Kanematsu T, Yagisawa H, Nakayama KI, Maeda K, Hirata M. 2005. Role of PRIP-1, a novel Ins(1,4,5)P-3 binding protein, in Ins(1,4,5)P-3-mediated, Ca2+ signaling. J Cell Physiol 202:422-433.
21. Ishihara H, Sasaoka T, Hori H, Wada T, Hirai H, Haruta T, Langlois WJ, Kobayashi M. 1999. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Biochem Biophys Res Commun 260:265-272.
22. Ishihara H, Sasaoka T, Ishiki M, Wada T, Hori H, Kagawa S, Kobayashi M. 2002. Membrane localization of Src homology 2-containing inositol 5′-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in RatI fibroblasts overexpressing insulin receptors. Mol Endocrinol 16:2371-2381.
23. Kagawa S, Sasaoka T, Yaguchi S, Ishihara H, Tsuneki H, Murakami S, Fukui K, Wada T, Kobayashi S, Kimura I, Kobayashi M. 2005. Impact of Src homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. J Clin Endocrinol Metab 90:2911-2919.
24. Li M, Ren DC, Iseki M, Takaki S, Rui L. 2006. Differential role of SH2-Band APS in regulating energy and glucose homeostasis. Endocrinology 147:2163-2170.
25. Liu J, Kimura A, Baumann CA, Saltiel AR. 2002. APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol Cell Biol 22:3599-3609.
26. Maffucci T, Falasca M. 2001. Specificity in pleckstrin homology (PH) domain membrane targeting: A role for a phosphoinositide-protein co-operative mechanism. FEBS Lett 506:173-179.
27. Marion E, Kaisaki PJ, Pouillon V, Gueydan C, Levy JC, Bodson A, Krzentowski G, Daubresse JC, Mockel J, Behrends J, Servais G, Szpirer C, Kruys W, Gauguier D, Schurmans S. 2002. The gene INPPLI, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 51:2012-2017.
28. Minami A, Iseki M, Kishi K, Wang M, Ogura M, Furukawa N, Hayashi S, Yamada M, Obata T, Takeshita Y, Nakaya Y, Bando Y, Izumi K, Moodie SA, Kajiura F, Matsumoto M, Takatsu K, Takaki S, Ebina Y. 2003. Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes 52:2657-2665.
29. Moodie SA, Alleman-Sposeto J, Gustafson TA. 1999. Identification of the APS protein as a novel insulin receptor substrate. J Biol Chem 274:11186-11193.
30. Muraille E, Pesesse X, Kuntz C, Erneux C. 1999. Distribution ofthe Src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Biochem J 342:697-705.
31. Murakami S, Sasaoka T, Wada T, Fukui K, Nagira K, Ishihara H, Usui I, Kobayashi M. 2004. Impact of Src homology 2-containing inositol 5′-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acids. Endocrinology 145:3215-3223.
32. Paternotte N, Zhang J, Vandenbroere I, Backers K, Blero D, Kioka N, Vanderwinden JM, Pirson I, Erneux C 2005. SHIP2 interaction with the cytoskeletal protein Vinexin. FEBS J 272:6052-6066.
33. Pesesse X, Deleu S, Desmedt F, Drayer L, Erneux C. 1997. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem Biophys Res Commun 239:697-700.
34. Pesesse X, Moreau C, Drayer AL, Woscholski R, Parker P, Erneux C. 1998. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity. FEBS Lett 437:301-303.
35. Pesesse X, Dewaste V, De Smedt F, Laffargue M, Giuriato S, Moreau C, Payrastre B, Erneux C 2001. The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and de phosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells. J Biol Chem 276:28348-28355.
36. Prasad NK, Decker SJ. 2005. SH2-containing 5′-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent downregulation of the epidermal growth factor receptor. J Biol Chem 280:13 129-13136.
37. Prasad N, Topping RS, Decker SJ. 2001. SH2-containing inositol 5′-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading. Mol Cell Biol 21:1416-1428.
38. Prasad N, Topping RS, Decker SJ. 2002. Src family tyrosine kinases regulate adhesion-dependent tyrosine phosphorylation of 5′-inositol phosphatase SHIP2 during cell attachment and spreading on collagen I. J Cell Sci 115:3807-3815.
39. Sasaoka T, Hori H, Wada T, Ishiki M, Haruta T, Ishihara H, Kobayashi M. 2001. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Diabetologia 44:1258-1267.
40. Sasaoka T, Kikuchi K, Wada T, Sato A, Hori H, Murakami S, Fukui K, Ishihara H, Aota R, Kimura I, Kobayashi M. 2003. Dual role of Src homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells. Endocrinology 144:4204-4214.
41. Sasaoka T, Wada T, Fukui K, Murakami S, Ishihara H, Suzuki R, Tobe K, Kadowaki T, Kobayashi M. 2004. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes. J Biol Chem 279:14835-14843.
42. Sleeman MW, Wortley KE, Lai KMV, Gowen LC, Kintner J, Kline WO, Garcia K, Stitt TN, Yancopoulos GD, Wiegand SJ, Glass DJ. 2005. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity (vol 11, pg 199, 2005). Nat Med 11:353.
43. Steuve S, Devosse T, Lauwers E, Vanderwinden JM, Andre B, Courtoy PJ, Pirson I. 2006. Rhophilin-2 is targeted to late-endosomal structures of the vesicular machinery in the presence of activated RhoB. Exp Cell Res 312:3981-3989.
44. Vandenbroere I, Paternotte N, Dumont JE, Erneux C, Pirson I. 2003. The c-Cbl-associated protein and c-Cbl are two new partners ofthe SH2-containing inositol polyphosphate 5-phosphatase SHIP2. Biochem Biophys Res Commun 300:494-500.
45. Wada T, Sasaoka T, Funaki M, Hori H, Murakami S, Ishiki M, Haruta T, Asano T, Ogawa W, Ishihara H, Kobayashi M. 2001. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-LI adipocytes via its 5′-phosphatase catalytic activity. Mol Cell Biol 21:1633-1646.
46. Wang YJ, Keogh RJ, Hunter MG, Mitchell CA, Frey RS, Javaid K, Malik AB, Schurmans S, Tridandapani S, Marsh CB. 2004. SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling. J Immunol 173:6820-6830.
47. Wilcox A, Katsanakis KD, Bheda F, Pillay TS. 2004. Asb6, an adipocyte-specific ankyrin and SOCS box protein, interacts with APS to enable recruitment of elongins B and C to the insulin receptor signaling complex. J Biol Chem 279:38881-38888.
48. Yokouchi M, Suzuki R, Masuhara M, Komiya S, Inoue A, Yoshimura A. 1997. Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation. Oncogene 15:7-15.